PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,962,623 | -28.6% | 1,732,172 | -1.4% | 0.04% | -25.5% |
| Q2 2023 | $25,162,058 | +100.1% | 1,757,127 | -0.2% | 0.05% | +88.9% |
| Q1 2023 | $12,574,903 | -36.4% | 1,761,191 | 0.0% | 0.03% | -40.0% |
| Q4 2022 | $19,760,563 | +1.3% | 1,761,191 | 0.0% | 0.04% | -6.2% |
| Q3 2022 | $19,514,000 | +38.0% | 1,761,191 | +5.1% | 0.05% | +41.2% |
| Q2 2022 | $14,140,000 | -6.0% | 1,675,488 | +51.7% | 0.03% | +9.7% |
| Q1 2022 | $15,036,000 | -41.9% | 1,104,759 | -16.0% | 0.03% | -36.7% |
| Q4 2021 | $25,880,000 | -31.1% | 1,315,717 | +12.4% | 0.05% | -37.2% |
| Q3 2021 | $37,563,000 | -9.0% | 1,170,224 | -4.1% | 0.08% | -6.0% |
| Q2 2021 | $41,297,000 | -11.3% | 1,220,010 | -1.6% | 0.08% | -17.0% |
| Q1 2021 | $46,553,000 | +14.4% | 1,239,462 | +1.2% | 0.10% | +8.7% |
| Q4 2020 | $40,679,000 | +24.3% | 1,224,552 | +37.2% | 0.09% | +10.8% |
| Q3 2020 | $32,737,000 | +17.0% | 892,792 | +5.0% | 0.08% | +9.2% |
| Q2 2020 | $27,973,000 | +81.3% | 850,003 | +42.3% | 0.08% | +46.2% |
| Q1 2020 | $15,427,000 | -19.7% | 597,492 | -3.1% | 0.05% | +2.0% |
| Q4 2019 | $19,208,000 | – | 616,857 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |